| View |
|
DR-XY28231
|
Famotidine
|
None
|
20 mg
|
Tablet
|
H2 Receptor Antagonist
|
Swisspharma Research Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
23 March 2021
|
22 January 2026
|
| View |
|
DR-XY28233
|
Sulfacetamide Sodium
|
Vistasulf
|
0.1
|
Ophthalmic Solution
|
Anti-infective (Sulfonamide)
|
E.L. Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
15 February 2023
|
13 December 2027
|
| View |
|
DR-XY28249
|
Co-Amoxiclav
|
Natravox
|
500mg/125mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
04 October 2022
|
27 January 2028
|
| View |
|
DR-XY28251
|
Co-amoxiclav
|
Natravox
|
375mg
|
Film-coated tablet
|
Antibacterial (Penicillin/Beta-lactamase inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 August 2022
|
27 January 2028
|
| View |
|
DR-XY28252
|
Co-Amoxiclav
|
Sullivan
|
250 mg/62.5 mg per 5 mL
|
Powder For Suspension
|
Antibacterial (Penicillin/Beta-Lactamse Inhibitor Combination)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 December 2022
|
27 January 2028
|
| View |
|
DR-XY28255
|
Metformin (As Hydrochloride) + Glibenclamide
|
Glucovance
|
500 mg/5 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drugs (Biguanides/Sulfonylureas)
|
Merck Sante s.a.s.
|
France
|
Automatic Renewal
|
29 September 2022
|
05 March 2028
|
| View |
|
DR-XY28270
|
Ofloxacin (as hydrochloride)
|
Qinolon
|
200 mg/ 100 mL (2mg/ mL)
|
Solution For Infusion (Iv)
|
Antibacterial (Fluoroquinolones)
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
13 March 2023
|
30 January 2028
|
| View |
|
DR-XY28272
|
Ofloxacin
|
Inoflox
|
200 mg/ 100 mL (2mg/ mL)
|
Solution For Infusion (Iv)
|
Antibacterial (Fluoroquinolones)
|
Amherst Parenterals, Inc.
|
Philippines
|
Automatic Renewal
|
19 January 2023
|
30 January 2028
|
| View |
|
DR-XY28303
|
Furosemide
|
None
|
10mg/Ml
|
Solution for Injection (I.M. /I.V.)
|
-
|
Karnataka Antibiotics & Pharmaceuticals Limited
|
India
|
-
|
02 January 2020
|
10 February 2025
|
| View |
|
DR-XY28309
|
Metoclopramide (As Hydrochloride)
|
Clomitene
|
5 mg/mL
|
Solution For Injection (IM/IV)
|
Gastrokinetic (Prokinetic)
|
L.B.S. Laboratory Limited Partnership
|
Thailand
|
Automatic Renewal
|
13 March 2023
|
10 February 2028
|
| View |
DR-XY28329_PI_01.pdf
|
DR-XY28329
|
Amisulpride
|
Solian
|
400mg
|
Tablet
|
Antipsychotic
|
Sanofi Winthrop Industrie
|
France
|
Automatic Renewal
|
04 October 2021
|
28 December 2026
|
| View |
|
DR-XY28332
|
Chloramphenicol
|
None
|
5mg/mL (0.5%
|
Sterile Otic Suspension
|
Antibacterial (Amphenicol)
|
El Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 March 2023
|
17 February 2028
|
| View |
|
DR-XY28353
|
Salbutamol (As Sulfate) 2 Mg/Ml Solution For Nebulization
|
Hivent Ds
|
Each mL contains 2 mg Salbutamol (as sulfate)
|
Solution For Nebulization
|
Selective beta-2-adrenoreceptor agonist
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
28 October 2022
|
20 February 2028
|
| View |
|
DR-XY28362
|
Rifampicin
|
Rimaped
|
200 mg/ 5 mL
|
Suspension
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
19 November 2020
|
18 October 2025
|
| View |
|
DR-XY28378
|
Sulfacetamide Sodium/ Prednisolone Acetate
|
STERILID-V
|
10% / 0.25%
|
Ophthalmic Suspension
|
Anti-inflammatory/Anti-infective
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
28 April 2022
|
16 April 2027
|
| View |
|
DR-XY28382
|
Metformin (As Hydrochloride) + Glibenclamide
|
Glucovance
|
500 mg/2.5 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drugs (Biguanides/Sulfonylureas)
|
Merck Sante s.a.s.
|
France
|
Automatic Renewal
|
28 September 2022
|
05 March 2028
|
| View |
|
DR-XY28399
|
Chloramphenicol
|
None
|
5mg/mL (0.5%
|
Sterile Ophthalmic Suspension Eye Drops
|
Antibacterial (Amphenicol)
|
El Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
01 February 2023
|
11 March 2028
|
| View |
|
DR-XY28402
|
Carbomer
|
Siccafluid
|
2.5 mg/g (0.25%)
|
Ophthalmic Gel
|
Artificial Tears
|
URSAPHARM ARZNEIMITTEL GmbH
|
Germany
|
Initial (Variation)
|
13 October 2023
|
13 October 2028
|
| View |
|
DR-XY28408
|
PACLITAXEL
|
UNITAXEL
|
6 mg/ mL
|
Solution for I.V. Infusion
|
Antineoplastic
|
Korea United Pharm. Inc.
|
Korea
|
Automatic Renewal
|
19 July 2023
|
04 October 2028
|
| View |
|
DR-XY28418
|
Ciprofloxacin (As Lactate)
|
Zalvos
|
2 mg/mL
|
Solution For Iv Infusion
|
Antibacterial (Fluoroquinolone)
|
Demo S.A. Pharmaceutical Industry
|
Greece
|
Automatic Renewal
|
20 January 2023
|
17 March 2028
|